Sofgen Pharma S.A 20-F for FY2024
Sofgen Pharma S.A. (PROCF)
20-F
2026-03-16
For: 2024-12-31
View Original
Added on
April 06, 2026
About this 20-F
Sofgen Pharma S.A filed this 20-F on March 16, 2026, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $373.8M
- down 11.8% from $423.75M a year earlier
- Net loss
- $68.3M
- compared with net income of $40.34M a year earlier
- Diluted EPS
- -$0.68
- compared with $0.40 a year earlier